Mark R. Fielden

3.9k total citations
42 papers, 1.7k citations indexed

About

Mark R. Fielden is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Mark R. Fielden has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Health, Toxicology and Mutagenesis and 10 papers in Cancer Research. Recurrent topics in Mark R. Fielden's work include Effects and risks of endocrine disrupting chemicals (8 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Gene expression and cancer classification (6 papers). Mark R. Fielden is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (8 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Gene expression and cancer classification (6 papers). Mark R. Fielden collaborates with scholars based in United States, Canada and Switzerland. Mark R. Fielden's co-authors include Tim Zacharewski, Kyle L. Kolaja, Richard Brennan, Jeremy Gollub, Yanni Sun, Darrell R. Boverhof, Claudio Sorrentino, Wenyue Hu, Lyle D. Burgoon and Michael S. Denison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Bioinformatics.

In The Last Decade

Mark R. Fielden

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Fielden United States 24 659 504 332 225 181 42 1.7k
Mirjam Luijten Netherlands 29 1.1k 1.6× 889 1.8× 815 2.5× 212 0.9× 164 0.9× 102 2.8k
Atsushi Ono Japan 27 1.0k 1.6× 357 0.7× 343 1.0× 407 1.8× 285 1.6× 127 2.4k
Carl L. Alden United States 22 397 0.6× 276 0.5× 441 1.3× 88 0.4× 180 1.0× 65 1.4k
J. Craig Rowlands United States 27 542 0.8× 985 2.0× 579 1.7× 185 0.8× 169 0.9× 59 2.1k
Chao Quan China 30 1.0k 1.5× 412 0.8× 210 0.6× 90 0.4× 34 0.2× 74 2.6k
Joost H.M. van Delft Netherlands 33 1.3k 2.0× 638 1.3× 1.0k 3.0× 178 0.8× 321 1.8× 96 2.7k
Jolene Wiegers United States 13 1.6k 2.5× 305 0.6× 318 1.0× 766 3.4× 259 1.4× 17 2.7k
Cecile M. Krejsa United States 19 724 1.1× 181 0.4× 98 0.3× 211 0.9× 246 1.4× 39 1.8k
Craig B. Marcus United States 22 542 0.8× 225 0.4× 221 0.7× 46 0.2× 416 2.3× 51 1.4k
Üzen Savas United States 24 767 1.2× 374 0.7× 436 1.3× 136 0.6× 940 5.2× 25 1.9k

Countries citing papers authored by Mark R. Fielden

Since Specialization
Citations

This map shows the geographic impact of Mark R. Fielden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Fielden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Fielden more than expected).

Fields of papers citing papers by Mark R. Fielden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Fielden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Fielden. The network helps show where Mark R. Fielden may publish in the future.

Co-authorship network of co-authors of Mark R. Fielden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Fielden. A scholar is included among the top collaborators of Mark R. Fielden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Fielden. Mark R. Fielden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carss, Keren, Aimée M. Deaton, Alberto Del Río-Espínola, et al.. (2022). Using human genetics to improve safety assessment of therapeutics. Nature Reviews Drug Discovery. 22(2). 145–162. 42 indexed citations
2.
Valentine, Charles C., Robert R. Young, Mark R. Fielden, et al.. (2020). Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing. Proceedings of the National Academy of Sciences. 117(52). 33414–33425. 75 indexed citations
3.
Bunin, Deborah I., James Bakke, Carol E. Green, et al.. (2019). Romiplostim (Nplate®) as an effective radiation countermeasure to improve survival and platelet recovery in mice. International Journal of Radiation Biology. 96(1). 145–154. 43 indexed citations
4.
Fielden, Mark R., Lucas D. Ward, Sheroy Minocherhomji, et al.. (2017). Modernizing Human Cancer Risk Assessment of Therapeutics. Trends in Pharmacological Sciences. 39(3). 232–247. 14 indexed citations
5.
Sawant, Satin G., Mark R. Fielden, & Kurt A. Black. (2014). Evaluation of genotoxicity testing of FDA approved large molecule therapeutics. Regulatory Toxicology and Pharmacology. 70(1). 87–97. 14 indexed citations
6.
Fielden, Mark R., Alex Adai, Robert T. Dunn, et al.. (2011). Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat. Toxicological Sciences. 124(1). 54–74. 41 indexed citations
7.
Mikaelian, Igor, Andreas Buneß, Erik Rasmussen, et al.. (2010). Primary Endothelial Damage Is the Mechanism of Cardiotoxicity of Tubulin-Binding Drugs. Toxicological Sciences. 117(1). 144–151. 43 indexed citations
8.
Fielden, Mark R., Hirdesh Uppal, Donald Button, et al.. (2009). Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans. Experimental and Toxicologic Pathology. 62(6). 607–613. 7 indexed citations
9.
Guan, Ping, Andrew Olaharski, Mark R. Fielden, et al.. (2008). Biomarkers of carcinogenicity and their roles in drug discovery and development. Expert Review of Clinical Pharmacology. 1(6). 759–771. 1 indexed citations
10.
Wang, Er‐jia, et al.. (2008). Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology. 246(2-3). 91–100. 89 indexed citations
11.
Fielden, Mark R., Richard Brennan, & Jeremy Gollub. (2007). A Gene Expression Biomarker Provides Early Prediction and Mechanistic Assessment of Hepatic Tumor Induction by Nongenotoxic Chemicals. Toxicological Sciences. 99(1). 90–100. 130 indexed citations
12.
Hu, Wenyue, Claudio Sorrentino, Michael S. Denison, Kyle L. Kolaja, & Mark R. Fielden. (2007). Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro. Molecular Pharmacology. 71(6). 1475–1486. 176 indexed citations
13.
Fielden, Mark R., Cecelia I. Pearson, Richard Brennan, & Kyle L. Kolaja. (2005). Preclinical Drug Safety Analysis by Chemogenomic Profiling in the Liver. PubMed. 5(3). 161–171. 17 indexed citations
14.
Sun, Yanni, Darrell R. Boverhof, Lyle D. Burgoon, Mark R. Fielden, & Tim Zacharewski. (2004). Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Research. 32(15). 4512–4523. 174 indexed citations
15.
16.
Fielden, Mark R., Jason Matthews, K. C. Fertuck, Robert G. Halgren, & Tim Zacharewski. (2002). In Silico Approaches to Mechanistic and Predictive Toxicology: An Introduction to Bioinformatics for Toxicologists. Critical Reviews in Toxicology. 32(2). 67–112. 27 indexed citations
17.
Fielden, Mark R. & Tim Zacharewski. (2001). Challenges and Limitations of Gene Expression Profiling in Mechanistic and Predictive Toxicology. Toxicological Sciences. 60(1). 6–10. 108 indexed citations
18.
Fielden, Mark R., Robert G. Halgren, Colleen Tashiro, et al.. (2001). Effects of gestational and lactational exposure to Aroclor 1242 on sperm quality and in vitro fertility in early adult and middle-aged mice. Reproductive Toxicology. 15(3). 281–292. 38 indexed citations
19.
Sherry, James P., et al.. (1999). An ELISA for brown trout (Salmo trutta) vitellogenin and its use in bioassays for environmental estrogens. The Science of The Total Environment. 225(1-2). 13–31. 53 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirjam Luijten Breakdown of academic impact, for papers by Atsushi Ono Breakdown of academic impact, for papers by Carl L. Alden Breakdown of academic impact, for papers by J. Craig Rowlands Breakdown of academic impact, for papers by Chao Quan Breakdown of academic impact, for papers by Joost H.M. van Delft Breakdown of academic impact, for papers by Jolene Wiegers Breakdown of academic impact, for papers by Cecile M. Krejsa Breakdown of academic impact, for papers by Craig B. Marcus Breakdown of academic impact, for papers by Üzen Savas
Rankless by CCL
2026